These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 25693639)
1. Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides. Zhang Q; Tang J; Ran R; Liu Y; Zhang Z; Gao H; He Q Drug Deliv; 2016 May; 23(4):1163-70. PubMed ID: 25693639 [TBL] [Abstract][Full Text] [Related]
2. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide. Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system. Zhang Q; Ran R; Zhang L; Liu Y; Mei L; Zhang Z; Gao H; He Q J Control Release; 2015 Jan; 197():208-18. PubMed ID: 25445692 [TBL] [Abstract][Full Text] [Related]
4. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517 [TBL] [Abstract][Full Text] [Related]
5. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312 [TBL] [Abstract][Full Text] [Related]
6. [The construction of cell-penetrating peptide R8 and pH sensitive cleavable polyethylene glycols co-modified liposomes]. Zhang L; Wang Y; Gao HL; He Q Yao Xue Xue Bao; 2015 Jun; 50(6):760-6. PubMed ID: 26521450 [TBL] [Abstract][Full Text] [Related]
7. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer. Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545 [TBL] [Abstract][Full Text] [Related]
8. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG. Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209 [TBL] [Abstract][Full Text] [Related]
9. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery. Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613 [No Abstract] [Full Text] [Related]
11. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol). Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709 [TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Chen D; Jiang X; Liu J; Jin X; Zhang C; Ping Q Artif Cells Blood Substit Immobil Biotechnol; 2010 May; 38(3):136-42. PubMed ID: 20337549 [No Abstract] [Full Text] [Related]
13. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice. Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011 [TBL] [Abstract][Full Text] [Related]
15. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system. Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640 [TBL] [Abstract][Full Text] [Related]
16. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer. Xia T; He Q; Shi K; Wang Y; Yu Q; Zhang L; Zhang Q; Gao H; Ma L; Liu J Pharm Dev Technol; 2018 Jan; 23(1):13-21. PubMed ID: 27884084 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455 [TBL] [Abstract][Full Text] [Related]
18. A novel approach to overcome multidrug resistance: utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors. Yoshizawa Y; Ogawara K; Kimura T; Higaki K Eur J Pharm Sci; 2014 Oct; 62():274-80. PubMed ID: 24956463 [TBL] [Abstract][Full Text] [Related]
19. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582 [TBL] [Abstract][Full Text] [Related]
20. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]